ICEM Trademark

Trademark Overview


On Wednesday, January 8, 2025, a trademark application was filed for ICEM with the United States Patent and Trademark Office. The USPTO has given the ICEM trademark a serial number of 79416327. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Monday, February 16, 2026. This trademark is owned by Epi-Minder Pty Ltd. The ICEM trademark is filed in the Medical Instrument Products category with the following description:

Medical apparatus and instruments for use in the diagnosis, monitoring, management and treatment of neurological conditions and central nervous system disorders, namely, epilepsy, seizure control, sleep apnea, sleep disorders, psychosis, dementia, Alzheimer's disease and for brain machine interfacing, namely, neural control of artificial limb prosthetics; electronic medical apparatus for use in the diagnosis, monitoring, management and treatment of neurological conditions and central nervous system disorders, namely, epilepsy, seizure control, sleep apnea, sleep disorders, psychosis, dementia, Alzheimer's disease and for brain machine interfacing, namely, neural control of artificial limb prosthetics; medical diagnostic devices and instruments for use in the diagnosis, monitoring, management and treatment of neurological conditions and central nervous system disorders, namely, epilepsy, seizure control, sleep apnea, sleep disorders, psychosis, dementia, Alzheimer's disease and for brai...
icem

General Information


Serial Number79416327
Word MarkICEM
Filing DateWednesday, January 8, 2025
Status681 - PUBLICATION/ISSUE REVIEW COMPLETE
Status DateMonday, February 16, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 10, 2026

Trademark Statements


Goods and ServicesMedical apparatus and instruments for use in the diagnosis, monitoring, management and treatment of neurological conditions and central nervous system disorders, namely, epilepsy, seizure control, sleep apnea, sleep disorders, psychosis, dementia, Alzheimer's disease and for brain machine interfacing, namely, neural control of artificial limb prosthetics; electronic medical apparatus for use in the diagnosis, monitoring, management and treatment of neurological conditions and central nervous system disorders, namely, epilepsy, seizure control, sleep apnea, sleep disorders, psychosis, dementia, Alzheimer's disease and for brain machine interfacing, namely, neural control of artificial limb prosthetics; medical diagnostic devices and instruments for use in the diagnosis, monitoring, management and treatment of neurological conditions and central nervous system disorders, namely, epilepsy, seizure control, sleep apnea, sleep disorders, psychosis, dementia, Alzheimer's disease and for brain machine interfacing, namely, neural control of artificial limb prosthetics; medical devices and instruments for monitoring and treating health and medical conditions, namely, epilepsy, seizure control, sleep apnea, sleep disorders, psychosis, dementia, Alzheimer's disease and for brain machine interfacing, namely, neural control of artificial limb prosthetics; medical implants made of artificial materials for use in the diagnosis, monitoring, management and treatment of neurological conditions and central nervous system disorders, namely, epilepsy, seizure control, sleep apnea, sleep disorders, psychosis, dementia, Alzheimer's disease and for brain machine interfacing, namely, neural control of artificial limb prosthetics; wearable medical devices for use in the diagnosis, monitoring, management and treatment of neurological conditions and central nervous system disorders, namely, epilepsy, seizure control, sleep apnea, sleep disorders, psychosis, dementia, Alzheimer's disease and for brain machine interfacing, namely, neural control of artificial limb prosthetics; apparatus for use in the diagnosis, monitoring and treatment of neurological conditions and central nervous system disorders, namely, epilepsy, seizure control, sleep apnea, sleep disorders, psychosis, dementia, Alzheimer's disease and for brain machine interfacing, namely, neural control of artificial limb prosthetics; sensors being measurement apparatus for medical use, namely, the monitoring, management and treatment of neurological conditions and central nervous system disorders, namely, epilepsy, seizure control, sleep apnea, sleep disorders, psychosis, dementia, Alzheimer's disease and for brain machine interfacing, namely, neural control of artificial limb prosthetics; none of the aforementioned goods being syringes; electrodes for medical use

Classification Information


International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateThursday, February 6, 2025
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameEpiminder Limited
Party Type11 - New Owner Before Publication
Legal Entity Type99 - Other
AddressAU

Party NameEpi-Minder Pty Ltd
Party Type10 - Original Applicant
Legal Entity Type82 - NOT AVAILABLE
AddressAU

Trademark Events


Event DateEvent Description
Thursday, February 6, 2025SN ASSIGNED FOR SECT 66A APPL FROM IB
Tuesday, September 9, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, September 9, 2025APPLICATION FILING RECEIPT MAILED
Wednesday, September 10, 2025ASSIGNED TO EXAMINER
Wednesday, September 10, 2025NON-FINAL ACTION WRITTEN
Thursday, September 11, 2025NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Wednesday, October 29, 2025REFUSAL PROCESSED BY MPU
Wednesday, October 29, 2025NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Saturday, November 22, 2025REFUSAL PROCESSED BY IB
Tuesday, January 13, 2026TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, January 13, 2026APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, January 13, 2026TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, January 13, 2026ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, January 13, 2026TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Thursday, January 22, 2026CHANGE OF NAME/ADDRESS REC'D FROM IB
Tuesday, February 10, 2026EXAMINERS AMENDMENT -WRITTEN
Tuesday, February 10, 2026EXAMINERS AMENDMENT E-MAILED
Tuesday, February 10, 2026NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, February 10, 2026EXAMINER'S AMENDMENT ENTERED
Tuesday, February 10, 2026APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, February 17, 2026NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, February 18, 2026NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB